VOR
Vor BiopharmaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
VOR vs peer average
40/100
VOR vs. peer average (D vs. C)
Grade spread
B 2 · C 4 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
MGTX is the first available peer comparator.
Similar-market-cap biotechnology candidate, but no direct telitacicept or autoimmune-program overlap is established; not a valuation anchor.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VOR
Vor Biopharma
MGTX
MeiraGTx
Grade
D
D
Momentum
39
14
Value
41
64
Sentiment
49
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MGTX
VOR / MGTX
Grade Position
Below peers
VOR vs. peer average (D vs. C)
40/100
Momentum
39
VORValue
41
MGTXSentiment
49
VORRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VOR
MGTX is the first peer returned for this comparison set.